APOB and atherosclerosis: We could generate and maintain a very robust CD8 T cell response against 3 epitopes over 8 weeks, however in contrast to other studies which report CD8 T cell mediated protection from atherosclerosis resulting from vaccination with ApoB100 derived peptides13,15, boosting CD8 T cell immunity towards ApoB100 did not reduce atherosclerosis in our hands.